BE585579A - Procédé pour la préparation d'une composition permettant la libération prolongée d'un médicament. - Google Patents

Procédé pour la préparation d'une composition permettant la libération prolongée d'un médicament.

Info

Publication number
BE585579A
BE585579A BE585579A BE585579A BE585579A BE 585579 A BE585579 A BE 585579A BE 585579 A BE585579 A BE 585579A BE 585579 A BE585579 A BE 585579A BE 585579 A BE585579 A BE 585579A
Authority
BE
Belgium
Prior art keywords
medicament
preparation
sustained release
composition allowing
allowing
Prior art date
Application number
BE585579A
Other languages
English (en)
Inventor
Clarence James Endicott
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of BE585579A publication Critical patent/BE585579A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
BE585579A 1958-12-19 1959-12-11 Procédé pour la préparation d'une composition permettant la libération prolongée d'un médicament. BE585579A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US781433A US3087860A (en) 1958-12-19 1958-12-19 Method of prolonging release of drug from a precompressed solid carrier

Publications (1)

Publication Number Publication Date
BE585579A true BE585579A (fr) 1960-04-01

Family

ID=25122720

Family Applications (1)

Application Number Title Priority Date Filing Date
BE585579A BE585579A (fr) 1958-12-19 1959-12-11 Procédé pour la préparation d'une composition permettant la libération prolongée d'un médicament.

Country Status (4)

Country Link
US (1) US3087860A (fr)
BE (1) BE585579A (fr)
ES (1) ES254048A1 (fr)
GB (1) GB908016A (fr)

Families Citing this family (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3138544A (en) * 1961-05-03 1964-06-23 British Drug Houses Canada Ltd Microbial sensitivity testing device
US3198700A (en) * 1961-05-29 1965-08-03 Blessings Inc Sedative tablet and method for producing the same
BE636865A (fr) * 1962-08-31
US3247066A (en) * 1962-09-12 1966-04-19 Parke Davis & Co Controlled release dosage form containing water-swellable beadlet
US3325365A (en) * 1963-04-02 1967-06-13 Ciba Geigy Corp Enteric composition for tablet compression coating
US3440320A (en) * 1964-06-18 1969-04-22 Mortimer D Sackler Chelated suppository and method of using same
US3453360A (en) * 1966-04-27 1969-07-01 Abbott Lab Universally useful stock material for manufacturing plastic dosage units by compression tableting processes
IE32806B1 (en) * 1968-05-21 1973-12-12 American Home Prod Sustained release drug composition
DE2239206A1 (de) * 1971-08-12 1973-03-15 Hydrophilics Int Inc Copolymer
US3995632A (en) * 1973-05-04 1976-12-07 Alza Corporation Osmotic dispenser
US4704284A (en) * 1982-08-12 1987-11-03 Pfizer Inc. Long-acting matrix tablet formulations
US4851231A (en) * 1982-12-13 1989-07-25 Alza Corporation System for delivering drug in selected environment of use
DE3314003A1 (de) * 1983-04-18 1984-10-18 Boehringer Ingelheim KG, 6507 Ingelheim Teilbare tablette mit verzoegerter wirkstofffreigabe und verfahren zu deren herstellung
US4863744A (en) * 1984-09-17 1989-09-05 Alza Corporation Intestine drug delivery
DE3505433A1 (de) * 1985-02-16 1986-08-21 Basf Ag, 6700 Ludwigshafen Direkttablettierhilfsmittel
US4851232A (en) * 1987-02-13 1989-07-25 Alza Corporation Drug delivery system with means for obtaining desirable in vivo release rate pattern
DE3827214A1 (de) * 1988-08-11 1990-02-15 Roehm Gmbh Retardierte arzneiform und verfahren zu ihrer herstellung
US5603956A (en) * 1990-11-27 1997-02-18 Labopharm Inc. Cross-linked enzymatically controlled drug release
US5153002A (en) * 1991-03-04 1992-10-06 University Of Montreal Biocompatible gradient controlled release implant
US5616343A (en) * 1993-03-25 1997-04-01 Labopharm, Inc. Cross-linked amylose as a binder/disintegrant in tablets
US5807575A (en) * 1997-02-14 1998-09-15 Rougier Inc. Manufacture of cross-linked amylose useful as a excipient for control release of active compounds
DE19732903A1 (de) 1997-07-30 1999-02-04 Falk Pharma Gmbh Pellet-Formulierung zur Behandlung des Intestinaltraktes
US6607748B1 (en) 2000-06-29 2003-08-19 Vincent Lenaerts Cross-linked high amylose starch for use in controlled-release pharmaceutical formulations and processes for its manufacture
DE10247037A1 (de) * 2002-10-09 2004-04-22 Abbott Gmbh & Co. Kg Herstellung von festen Dosierungsformen unter Verwendung eines vernetzten nichtthermoplastischen Trägers
US8487002B2 (en) * 2002-10-25 2013-07-16 Paladin Labs Inc. Controlled-release compositions
TWI319713B (en) * 2002-10-25 2010-01-21 Sustained-release tramadol formulations with 24-hour efficacy
US7225024B2 (en) 2003-09-30 2007-05-29 Cardiac Pacemakers, Inc. Sensors having protective eluting coating and method therefor
US20060172006A1 (en) * 2003-10-10 2006-08-03 Vincent Lenaerts Sustained-release tramadol formulations with 24-hour clinical efficacy
US20070009564A1 (en) * 2005-06-22 2007-01-11 Mcclain James B Drug/polymer composite materials and methods of making the same
US20090062909A1 (en) * 2005-07-15 2009-03-05 Micell Technologies, Inc. Stent with polymer coating containing amorphous rapamycin
ES2691646T3 (es) 2005-07-15 2018-11-28 Micell Technologies, Inc. Revestimientos poliméricos que contienen polvo de fármaco de morfología controlada
BRPI0615860B8 (pt) * 2005-09-09 2021-05-25 Labopharm Barbados Ltd composição farmacêutica de liberação prolongada monolítica sólida
ES2540059T3 (es) 2006-04-26 2015-07-08 Micell Technologies, Inc. Recubrimientos que contienen múltiples fármacos
WO2008042909A2 (fr) 2006-10-02 2008-04-10 Micell Technologies Inc. Sutures chirurgicales ayant une résistance accrue
WO2008052000A2 (fr) * 2006-10-23 2008-05-02 Micell Technologies, Inc. Support pour charger électriquement un substrat au cours de l'enduction
US11426494B2 (en) 2007-01-08 2022-08-30 MT Acquisition Holdings LLC Stents having biodegradable layers
US9737642B2 (en) 2007-01-08 2017-08-22 Micell Technologies, Inc. Stents having biodegradable layers
US9433516B2 (en) * 2007-04-17 2016-09-06 Micell Technologies, Inc. Stents having controlled elution
WO2008131131A1 (fr) * 2007-04-17 2008-10-30 Micell Technologies, Inc. Endoprothèses vasculaires ayant des couches biodégradables
WO2008148013A1 (fr) * 2007-05-25 2008-12-04 Micell Technologies, Inc. Films de polymères pour le revêtement des dispositifs médicaux
WO2009051780A1 (fr) * 2007-10-19 2009-04-23 Micell Technologies, Inc. Endoprothèses vasculaires revêtues de médicament
EA020655B1 (ru) * 2008-04-17 2014-12-30 Миселл Текнолоджиз, Инк. Стенты, имеющие биорассасывающиеся слои
US9510856B2 (en) 2008-07-17 2016-12-06 Micell Technologies, Inc. Drug delivery medical device
CN102159257B (zh) * 2008-07-17 2015-11-25 米歇尔技术公司 药物递送医疗设备
US8865688B2 (en) * 2008-10-03 2014-10-21 Dr. Falk Pharma Gmbh Compositions and methods for treatment of bowel diseases with granulated mesalamine
US8834913B2 (en) * 2008-12-26 2014-09-16 Battelle Memorial Institute Medical implants and methods of making medical implants
EP2410954A4 (fr) * 2009-03-23 2014-03-05 Micell Technologies Inc Endoprothèses périphériques dotées de couches
WO2010111232A2 (fr) * 2009-03-23 2010-09-30 Micell Technologies, Inc. Dispositif médical d'administration de médicament
CA2756388C (fr) * 2009-03-23 2015-10-27 Micell Technologies, Inc. Polymeres biodegradables a faible teneur en impuretes acides
WO2010120552A2 (fr) * 2009-04-01 2010-10-21 Micell Technologies, Inc. Endoprothèses enduites
US11369498B2 (en) 2010-02-02 2022-06-28 MT Acquisition Holdings LLC Stent and stent delivery system with improved deliverability
US8795762B2 (en) * 2010-03-26 2014-08-05 Battelle Memorial Institute System and method for enhanced electrostatic deposition and surface coatings
US10232092B2 (en) 2010-04-22 2019-03-19 Micell Technologies, Inc. Stents and other devices having extracellular matrix coating
EP2593039B1 (fr) 2010-07-16 2022-11-30 Micell Technologies, Inc. Dispositif médical d'administration de médicament
US9636309B2 (en) 2010-09-09 2017-05-02 Micell Technologies, Inc. Macrolide dosage forms
US10464100B2 (en) 2011-05-31 2019-11-05 Micell Technologies, Inc. System and process for formation of a time-released, drug-eluting transferable coating
US10117972B2 (en) 2011-07-15 2018-11-06 Micell Technologies, Inc. Drug delivery medical device
US10188772B2 (en) 2011-10-18 2019-01-29 Micell Technologies, Inc. Drug delivery medical device
US11039943B2 (en) 2013-03-12 2021-06-22 Micell Technologies, Inc. Bioabsorbable biomedical implants
KR102079613B1 (ko) 2013-05-15 2020-02-20 미셀 테크놀로지즈, 인코포레이티드 생흡수성 생체의학적 임플란트

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA548310A (fr) * 1957-11-05 M. O. Honey Eric Diaphragmes pour usage dans procedes a echange d'ions
US312041A (en) * 1885-02-10 Process of making pills
USRE24090E (en) * 1955-11-15 Impregnated salt tablet
NL44885C (fr) * 1935-11-09
US2385920A (en) * 1941-12-19 1945-10-02 Pittsburgh Plate Glass Co Plasticization of plastics
US2478182A (en) * 1945-01-16 1949-08-09 William V Consolazio Sodium chloride tablet
GB665073A (en) * 1948-11-10 1952-01-16 Jacques Loewe Res Foundation I Process of preparing acid-sensitive drugs for oral administration and the product soproduced
US2955982A (en) * 1951-01-22 1960-10-11 Parmelee Pharmaceutical Compan Continuous process for internally reinforcing salt tablets
US2707201A (en) * 1951-05-05 1955-04-26 Richardson Co Porous storage battery separator and method of making
US2719093A (en) * 1952-06-03 1955-09-27 William H Voris Methods of applying plastic coatings
BE538663A (fr) * 1954-06-25
US2894289A (en) * 1956-03-01 1959-07-14 Dow Chemical Co Method of making permeselective membranes
NL112156C (fr) * 1956-08-07
US2877159A (en) * 1957-04-26 1959-03-10 Ciba Pharm Prod Inc Method for preparing tablet granulations
US2928771A (en) * 1957-07-22 1960-03-15 Strong Cobb And Company Inc Production of orally administrable controlled release medicaments
US2928769A (en) * 1957-07-22 1960-03-15 Strong Cobb And Company Inc Production of controlled release medicaments

Also Published As

Publication number Publication date
GB908016A (en) 1962-10-10
ES254048A1 (es) 1960-02-16
US3087860A (en) 1963-04-30

Similar Documents

Publication Publication Date Title
BE585579A (fr) Procédé pour la préparation d'une composition permettant la libération prolongée d'un médicament.
BE581447A (fr) Procédé pour la préparation de dérivés de 2,3-diméthoxy-benzohydroquinone-(1,4).
BE579006R (fr) Procédé de préparation d'esters.
OA00963A (fr) Procédé pour la préparation d'un sulfonamide.
OA00939A (fr) Procédé pour la préparation d'amino-isoxazoles.
CH322981A (fr) Procédé pour la préparation d'hypophosphites.
FR1245617A (fr) Procédé pour la préparation d'azacyclo-2,3-alcène-2-chloro-n-carbochlorures à partir de omega-lactames
FR1538951A (fr) Procédé pour la préparation d'une composition permettant la libération prolongée d'un médicament
OA00634A (fr) Procédé pour la préparation des 4-quinazolinones.
FR1241744A (fr) Procédé pour la préparation des o, o'-dihydroxybenzophénones
BE583647A (fr) Procédé pour la préparation d'hydrazides substitués.
BE583648A (fr) Procédé pour la préparation d'alpha-tocophérol.
OA00922A (fr) Procédé pour la préparation d'esters de 19-nortestérone.
BE580783A (fr) Procédé pour la préparation d'esters de methyl-pipéridyl-pentanol.
BE575468A (fr) Procédé pour la préparation de 5,6-diméthylbenzimidazolcobalamine.
BE576211A (fr) Procédé pour la préparation de 5,6-diméthylbenzimidazol-cobalamine.
BE578720A (fr) Procédé pour la préparation de 1,4-benzodiazépine-4-oxydes.
FR75260E (fr) Procédé pour la préparation de 4, 4'-dioxy-diphényl-pyridyl-méthanes
BE584215A (fr) Procédé pour la préparation d'alkylène-iminoquinones
FR1248428A (fr) Procédé pour la préparation de 5,6 -diméthylbenzimidazol-cobalamine
FR1247333A (fr) Procédé pour la préparation de 5,6-diméthylbenzimidazol-cobalamine
FR1269570A (fr) Procédé pour la préparation de 1, 4-benzodiazépine-4-oxydes
BE585466A (fr) Procédé pour la préparation d'hydrazides d'acides sulfoniques.
OA00950A (fr) Procédé pour la préparation de dérivés de tétrahydroisoquinoléine.
BE583433A (fr) Procédé pour la préparation de dérivés d'hydrazine monosubstitutes.